G-Tech Medical

Executive Summary

G-Tech Medical is a US-based medical device company developing the GutTracker®, a wireless, non-invasive dermal patch system for multi-day monitoring of gastrointestinal (GI) motility. The device captures myoelectrical signals from the stomach, small intestine, and colon simultaneously, providing comprehensive data for diagnosing and managing GI disorders. FDA-cleared for at-home use, the GutTracker enables real-life data collection, differentiating it from hospital-based alternatives. Founded in 2013 and headquartered in San Jose, CA, the company operates in the medical devices and digital health sectors, addressing a significant unmet need in GI diagnostics. With no disclosed funding or valuation, G-Tech appears to be an early-stage private firm seeking to commercialize its novel platform. The technology holds promise for improving outcomes in conditions like gastroparesis, IBS, and motility disorders, though adoption depends on clinical validation, reimbursement, and commercial execution.

Upcoming Catalysts (preview)

• Q1 2027Key Partnership with a Major GI Center or Hospital Network60% success
• Q4 2026Next-Generation Device Clearance or Expanded Indication50% success
• Q2 2027Series A or B Funding Round70% success